Informatics Core
信息学核心
基本信息
- 批准号:10471293
- 负责人:
- 金额:$ 50.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Adverse eventAnimalsAreaChemicalsClinicalClinical ResearchClinical assessmentsCollectionCommunitiesCommunity PracticeCompanionsComplementConsumptionDataData ReportingDisciplineDrug InteractionsDrug KineticsEducational workshopElementsEquilibriumEvaluationFAIR principlesFoundationsFundingHealth PersonnelHumanIn VitroInformaticsInterviewLeadershipLearningLinkManualsMarketingMetadataMethodsModelingMorphologic artifactsNatural Product DrugNatural ProductsPatientsPharmaceutical PreparationsPharmacologyPoisonProcessPublic HealthPublishingReportingResearchResearch DesignResearch PersonnelResourcesScientistSecureSeriesServicesSignal TransductionSourceSystemTimeVisualizationbaseclinical decision supportclinical practiceclinically significantcloud baseddata disseminationdata ecosystemdata formatdata repositorydata submissiondesignevidence baseexperienceimprovedin vitro Modelinnovationinsightnovelpharmacovigilancerepositorysymposiumsystems researchweb appweb servicesweb site
项目摘要
PROJECT SUMMARY OF THE INFORMATICS CORE
Natural product (NP)-drug interaction (NPDI) research spans several disciplines that include sourcing and
characterizing candidate NP materials (Analytical Core), in vitro and clinical assessment of NPDI liability
(Pharmacology Core), and data dissemination (Informatics Core). The existing Center of Excellence for NPDI
Research (NaPDI Center), currently in its fifth successful year, consists of world-renowned experts in each of
these areas and provides leadership for NPDI research. The Informatics Core has created a cloud-based data
repository that provides a secure workflow for manual NPDI study data entry and publishing. The repository is a
leading example of how to make NPDI data findable, accessible, interoperable, and reusable (FAIR). The long-
term sustainability of the data repository is dependent on its usefulness to relevant stakeholders. The Informatics
Core component of this renewal application proposes three SPECIFIC AIMS that refine the data repository and
expand the informatics power of the NaPDI Center. AIM 1: The Core will add features to the data repository to
increase its usefulness for a growing community of NPDI researchers, including companion R21 grantees. Such
features include a streamlined external data submission process based on simple-to-use data entry forms and
web services that use a common data format. New data summaries and visualizations will provide researchers
a complete evidence-based overview of each NP’s potential to precipitate pharmacokinetic NPDIs. AIM 2: The
Pharmacology Core previously developed a highly effective and robust method, termed the fulcrum model, for
selecting and prioritizing NPs as potential precipitants of NPDIs. Application of this novel model is currently a
time-consuming manual task. The Informatics Core will innovate the fulcrum model by developing an informatics-
based method to expedite the collection and summarization of data needed to apply the fulcrum model, providing
an automated and continual appraisal of high priority NPs to the Center and external NP researchers. The Core
will also innovate the identification of NPs by generating pharmacovigilance signal data for NPs using data from
poison center reports and two FDA adverse event reporting systems. This new feature will provide researchers
with important insight into the types of reported adverse events and concomitant exposures involving NPs. AIM
3: The Informatics Core will broaden the usage and utility of the data repository for both the research community
and clinical practice stakeholders. To capture scientists across the spectrum of disciplines in NPDI research, we
will expand our marketing strategy. To capture clinical practice stakeholders who consider potential NPDIs during
medication ordering and reconciliation activities, we will design NPDI clinical decision support artifacts and
services through a user-centered approach inspired by recent advances in decision support for potential drug-
drug interactions. Accomplishment of these aims will result in a learning NPDI research system that will improve
public health by helping patients avoid NPDIs.
信息学核心项目摘要
天然产物(NP)-药物相互作用(NPDI)研究跨越几个学科,包括采购和
表征候选NP材料(分析核心),体外和临床评估NPDI的可能性
(药理学核心)和数据传播(信息学核心)。现有的NPDI卓越中心
研究(NaPDI中心),目前在其成功的第五年,由世界知名的专家在每一个
这些领域,并为NPDI研究提供领导。Informatics Core创建了一个基于云的数据
存储库,为手动NPDI研究数据输入和发布提供安全的工作流。仓库是一个
如何使NPDI数据可查找、可访问、可互操作和可重用(FAIR)的领先示例。很长的-
数据储存库的长期可持续性取决于其对相关利益攸关方的用处。信息学
此更新应用程序的核心组件提出了三个具体目标,这些目标可以细化数据存储库,
扩大NaPDI中心的信息能力。目标1:核心将向数据存储库添加功能,
增加其对不断增长的NPDI研究人员社区的有用性,包括R21伙伴受赠者。等
其功能包括基于简单易用的数据输入表单的简化的外部数据提交流程,
使用通用数据格式的Web服务。新的数据摘要和可视化将为研究人员提供
每种NP促进药代动力学NPDI潜力的完整循证概述。目标2:
药理学核心先前开发了一种高效和稳健的方法,称为支点模型,用于
* 选择和优先考虑作为NPD潜在促进因素的NPs。这种新模式的应用目前是一种
耗时的手动任务。信息学核心将通过开发信息学-
的方法,以加快收集和总结的数据需要应用支点模型,提供
自动化和持续评估高优先级NP中心和外部NP研究人员。核心
还将通过使用以下数据生成NP的药物警戒信号数据来创新NP的识别
毒物中心报告和两个FDA不良事件报告系统。这项新功能将为研究人员提供
对报告的不良事件类型和涉及NP的伴随暴露有重要见解。目的
3:信息学核心将扩大数据存储库的使用和效用,
和临床实践的利益相关者。为了在NPDI研究中吸引跨学科的科学家,我们
将扩大我们的营销策略。捕获考虑潜在NPDI的临床实践利益相关者,
药物订购和协调活动,我们将设计NPDI临床决策支持工件,
通过以用户为中心的方法提供服务,这种方法受到潜在药物决策支持方面的最新进展的启发,
药物相互作用这些目标的实现将导致一个学习NPDI研究系统,
帮助患者避免NPDIs。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard David Boyce其他文献
Richard David Boyce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard David Boyce', 18)}}的其他基金
Addressing gaps in clinically useful evidence on drug-drug interactions
解决药物间相互作用的临床有用证据的差距
- 批准号:
9213391 - 财政年份:2014
- 资助金额:
$ 50.84万 - 项目类别:
Addressing gaps in clinically useful evidence on drug-drug interactions
解决药物间相互作用的临床有用证据的差距
- 批准号:
8614005 - 财政年份:2014
- 资助金额:
$ 50.84万 - 项目类别:
Improving medication safety for nursing home residents prescribed psychotropic dr
提高疗养院居民精神药物处方的用药安全
- 批准号:
8776906 - 财政年份:2013
- 资助金额:
$ 50.84万 - 项目类别:
Improving medication safety for nursing home residents prescribed psychotropic dr
提高疗养院居民精神药物处方的用药安全
- 批准号:
8634379 - 财政年份:2013
- 资助金额:
$ 50.84万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 50.84万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 50.84万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 50.84万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 50.84万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 50.84万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)














{{item.name}}会员




